Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06979284 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intravascular Ultrasound for Peripheral Artery Disease Revascularization

Study acronym: CLARITY
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 2 → 5 locations
    • Eligibility criteria shortened, about 20 words
    • Secondary endpoints revised (10)
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 1, 2025 to Dec 5, 2025
    • Study sites: 0 to 2
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine if IVUS use, as compared to angiography alone, prevent major adverse limb events (MALE) or binary restenosis (a greater than 50% re-narrowing of the treated artery) in adult patients who have CLTI and are undergoing percutaneous revascularization.
Trial Details
NCT Number NCT06979284
Lead Sponsor Hamilton Health Sciences Corporation
Conditions
(from sponsor)		 Peripheral Arterial Disease(PAD), Chronic Limb Threatening Ischemia, Intravascular Ultrasound, Major Adverse Limb Events, Restenosis
Related terms Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease
Enrollment 772 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov